Compare · CDNA vs UNH
CDNA vs UNH
Side-by-side comparison of CareDx Inc. (CDNA) and UnitedHealth Group Incorporated (UNH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both CDNA and UNH operate in Medical Specialities (Health Care), so they compete in similar markets.
- UNH is the larger of the two at $369.32B, about 285.4x CDNA ($1.29B).
- Over the past year, CDNA is up 32.1% and UNH is up 35.5% - UNH leads by 3.5 points.
- CDNA has been more active in the news (14 items in the past 4 weeks vs 9 for UNH).
- UNH has more recent analyst coverage (25 ratings vs 18 for CDNA).
- Company
- CareDx Inc.
- UnitedHealth Group Incorporated
- Price
- $25.04+0.04%
- $407.37+0.21%
- Market cap
- $1.29B
- $369.32B
- 1M return
- +16.19%
- +6.54%
- 1Y return
- +32.07%
- +35.52%
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- 2014
- News (4w)
- 14
- 9
- Recent ratings
- 18
- 25
CareDx Inc.
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It offers AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; and AlloSure Heart, a dd-cfDNA test to identify underlying cell injury leading to organ rejection. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; Olerup SBT, a product range for sequence-based typing of HLA alleles; QTYPE that enables precision in HLA typing at a low to intermediate resolution for samples that uses real-time polymerase chain reaction methodology; and TruSight HLA, a next generation sequencing (NGS) based high resolution typing solution. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Ottr, a transplant patient tracking software; and XynQAPI transplant quality tracking and waitlist management solutions, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors. CareDx, Inc. has a license agreement with Illumina, Inc. for the distribution, development and commercialization rights to NGS products and technologies; and Cibiltech SAS to commercialize KidneyCare iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. CareDx, Inc. was incorporated in 1998 and is headquartered in South San Francisco, California.
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services. The OptumHealth segment provides access to networks of care provider specialists, health management services, care delivery, consumer engagement, and financial services. This segment serves individuals directly through care delivery systems, employers, payers, and government entities. The OptumInsight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical, as well as develops programs in areas, such as step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated has partnership with the University of California, San Francisco to expand the mental health workforce in California. UnitedHealth Group Incorporated was incorporated in 1977 and is based in Minnetonka, Minnesota.
Latest CDNA
- President and CEO Hanna John Walter Jr sold $424,877 worth of shares (17,683 units at $24.03) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 631,959 units (SEC Form 4)
- Director Valantine Hannah was granted 9,795 shares and sold $279,728 worth of shares (12,103 units at $23.11) as part of a pre-agreed trading plan, decreasing direct ownership by 6% to 36,686 units (SEC Form 4)
- Director Cournoyer Christine was granted 9,795 shares, increasing direct ownership by 20% to 58,943 units (SEC Form 4)
- Director Riggsbee Richard Bryan was granted 9,795 shares, increasing direct ownership by 33% to 39,312 units (SEC Form 4)
- Director Cohen Fred E was granted 9,795 shares, increasing direct ownership by 6% to 165,060 units (SEC Form 4)
- Director Gunasekaran Suresh was granted 9,795 shares, increasing direct ownership by 36% to 37,248 units (SEC Form 4)
- Director Bickerstaff George was granted 9,795 shares, increasing direct ownership by 7% to 154,061 units (SEC Form 4)
- Director Goldberg Michael was granted 9,795 shares, increasing direct ownership by 5% to 195,737 units (SEC Form 4)
- CareDx Announces Second KOAR Analysis Published in the Journal of the American Society of Nephrology
- President and CEO Hanna John Walter Jr sold $528,443 worth of shares (21,998 units at $24.02) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 649,642 units (SEC Form 4)
Latest UNH
- Leerink Partners reiterated coverage on UnitedHealth with a new price target
- SEC Form 11-K filed by UnitedHealth Group Incorporated
- UnitedHealth Group Announces Earnings Release Date
- Chief Executive Officer, Optum Conway Patrick Hugh covered exercise/tax liability with 687 shares, decreasing direct ownership by 4% to 16,914 units (SEC Form 4)
- UnitedHealth Group Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- EVP & Chief Legal Officer Zaetta Christopher R covered exercise/tax liability with 134 shares, decreasing direct ownership by 0.80% to 16,582 units (SEC Form 4)
- Chief Executive Officer, Optum Conway Patrick Hugh covered exercise/tax liability with 204 shares, decreasing direct ownership by 1% to 17,601 units (SEC Form 4)
- UnitedHealth upgraded by BofA Securities with a new price target
- UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions
- UnitedHealthcare Eliminates Nearly Two-Thirds of Prior Authorization Requirements for Pediatric Care